Literature DB >> 7153334

Trimethoprim activity in media selective for Campylobacter jejuni.

C A Bopp, J G Wells, T J Barrett.   

Abstract

The activity of trimethoprim (TMP) in two selective media used for isolation of Campylobacter jejuni was evaluated. The two selective media, Campy-BAP and Skirrow medium, contain TMP in addition to other antimicrobial agents. The minimal inhibitory concentrations of TMP in blood agar base (basal agar for Skirrow medium) or brucella agar (basal agar for Campy-BAP) for three sensitive control organisms were compared with those in Mueller-Hinton agar, which contains low levels of thymidine. TMP was inactive in both blood agar base and brucella agar, even when lysed horse blood or thymidine phosphorylase was added. TMP had activity when used in combination with the other antimicrobial agents normally included in Skirrow medium and Campy-BAP, probably indicating synergism between TMP and one or more of the other antimicrobial agents. Sheep blood could be substituted for lysed horse blood in Skirrow medium without compromising the activity of TMP.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7153334      PMCID: PMC272481          DOI: 10.1128/jcm.16.5.808-812.1982

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  10 in total

1.  Identification of Harper-Cawston factor as thymidine phosphorylase and removal from media of substances interfering with susceptibility testing to sulfonamides and diaminopyrimidines.

Authors:  R Ferone; S R Bushby; J J Burchall; W D Moore; D Smith
Journal:  Antimicrob Agents Chemother       Date:  1975-01       Impact factor: 5.191

2.  Methods of testing combined antibiotic bactericidal action and the significance of the results.

Authors:  L P GARROD; P M WATERWORTH
Journal:  J Clin Pathol       Date:  1962-07       Impact factor: 3.411

3.  Campylobacter enteritis: a "new" disease.

Authors:  M B Skirrow
Journal:  Br Med J       Date:  1977-07-02

Review 4.  Trimethoprim-sulfamethoxazole: in vitro microbiological aspects.

Authors:  S R Bushby
Journal:  J Infect Dis       Date:  1973-11       Impact factor: 5.226

Review 5.  Inhibition of folate biosynthesis and function as a basis for chemotherapy.

Authors:  G H Hitchings; J J Burchall
Journal:  Adv Enzymol Relat Areas Mol Biol       Date:  1965

6.  Formylmethionyl-tRNA dependence of amino acid incorporation in extracts of trimethoprim-treated Escherichia coli.

Authors:  J Eisenstadt; P Lengyel
Journal:  Science       Date:  1966-10-28       Impact factor: 47.728

7.  Reversal of the antimicrobial activity of trimethoprim by thymidine in commercially prepared media.

Authors:  A E Koch; J J Burchall
Journal:  Appl Microbiol       Date:  1971-11

8.  Thymidine uptake and utilization in Escherichia coli: a new gene controlling nucleoside transport.

Authors:  M McKeown; M Kahn; P Hanawalt
Journal:  J Bacteriol       Date:  1976-05       Impact factor: 3.490

9.  Combined activity of sulfamethoxazole, trimethoprim, and polymyxin B against gram-negative bacilli.

Authors:  J E Rosenblatt; P R Stewart
Journal:  Antimicrob Agents Chemother       Date:  1974-07       Impact factor: 5.191

10.  Campylobacter enteritis: clinical and epidemiologic features.

Authors:  M J Blaser; I D Berkowitz; F M LaForce; J Cravens; L B Reller; W L Wang
Journal:  Ann Intern Med       Date:  1979-08       Impact factor: 25.391

  10 in total
  3 in total

1.  Comparison of basal media for culturing Campylobacter jejuni and Campylobacter coli.

Authors:  L K Ng; M E Stiles; D E Taylor
Journal:  J Clin Microbiol       Date:  1985-02       Impact factor: 5.948

2.  Granada medium for detection and identification of group B streptococci.

Authors:  M De La Rosa; R Villareal; D Vega; C Miranda; A Martinezbrocal
Journal:  J Clin Microbiol       Date:  1983-10       Impact factor: 5.948

3.  Inhibition of Campylobacter coli and Campylobacter jejuni by antibiotics used in selective growth media.

Authors:  L K Ng; M E Stiles; D E Taylor
Journal:  J Clin Microbiol       Date:  1985-10       Impact factor: 5.948

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.